Search alternatives:
substantial decrease » substantial increase (Expand Search), substantially increased (Expand Search)
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
cause decrease » caused decreased (Expand Search), use decreased (Expand Search), causes increased (Expand Search)
Showing 81 - 100 results of 20,345 for search '(( significant cause decrease ) OR ( significant ((substantial decrease) OR (small decrease)) ))', query time: 0.66s Refine Results
  1. 81
    Individual characteristics of the respondent in East African countries (n = 44,837).

    Individual characteristics of the respondent in East African countries (n = 44,837). by Samuel Hailegebreal (10297213)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 82
    Geniposide (Gen) significantly decreased the content of Hyp in bleomycin-induced PF mice’s lung tissue.

    Geniposide (Gen) significantly decreased the content of Hyp in bleomycin-induced PF mice’s lung tissue. by Jian-Bin Yin (19556105)

    Published 2024
    Save to List
    Saved in:
  3. 83
    Characteristics by group.

    Characteristics by group. by Arisa Kobayashi (4379608)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 84
    Kaplan–Meier curve for mortality related to CVD.

    Kaplan–Meier curve for mortality related to CVD. by Arisa Kobayashi (4379608)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 85
    Analysis of Significantly Different Bacteria.

    Analysis of Significantly Different Bacteria. by Xu Jia (187142)

    Published 2025
    Save to List
    Saved in:
  6. 86
    Moderate correlation (R<sup>2</sup> = 0.136 p = .0085) between Medicare prescriptions per 1,000 persons and the percentage of white population among the fifty US states.

    Moderate correlation (R<sup>2</sup> = 0.136 p = .0085) between Medicare prescriptions per 1,000 persons and the percentage of white population among the fifty US states. by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 87
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 <sup>a</sup> indicates ≥1.50 SD (17.9) from the mean (32.9), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 <sup>a</sup> indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 88
    Strong correlation (R<sup>2</sup> = 0.734 p < .0001) between Medicare prescriptions per 1,000 persons and Medicaid prescriptions per 1,000 persons among the fifty US states in 2019.

    Strong correlation (R<sup>2</sup> = 0.734 p < .0001) between Medicare prescriptions per 1,000 persons and Medicaid prescriptions per 1,000 persons among the fifty US states in 2019... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 89
    Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 <sup>a</sup> indicates ≥1.50 SD (20.2) from the mean (36.4), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 <sup>a</sup> indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 90
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 <sup>a</sup> indicates ≥1.50 SD (18.0) from the mean (33.1), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 <sup>a</sup> indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    Medicare clozapine data analysis.

    Medicare clozapine data analysis. by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 92
    Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 <sup>a</sup> indicates ≥1.50 SD (16.8) from the mean (31.0), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 <sup>a</sup> indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 93
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 <sup>a</sup> indicates ≥1.50 SD (16.0) from the mean (29.9), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 <sup>a</sup> indicates ≥1.50 SD (16.0) from the mean (29.9... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 94
    Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 <sup>a</sup> indicates ≥1.50 SD (19.2) from the mean (34.8), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 <sup>a</sup> indicates ≥1.50 SD (19.2) from the mean (34.... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 95
    Fig 3 -

    Fig 3 - by Nagendra Boopathy Senguttuvan (9027487)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 96
    Characteristics of included studies.

    Characteristics of included studies. by Nagendra Boopathy Senguttuvan (9027487)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 97
    Fig 4 -

    Fig 4 - by Nagendra Boopathy Senguttuvan (9027487)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 98
    The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) chart.

    The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) chart. by Nagendra Boopathy Senguttuvan (9027487)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 99
    Fig 2 -

    Fig 2 - by Nagendra Boopathy Senguttuvan (9027487)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 100
    Fig 5 -

    Fig 5 - by Nagendra Boopathy Senguttuvan (9027487)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: